CDSCO asks Sun Pharma to halt eye-care drug production over quality lapses
Indian drug regulators ordered Sun Pharma to halt eye-care drug production at its Assam plant over quality lapses, following the recall of 332 batches of ophthalmic products.
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.